News tagged with vaccine adjuvant
New discovery may lead the way to improved whooping cough vaccine
Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine. The findings could help reduce the incidence ...
Diseases, Conditions, Syndromes
May 13, 2013 |
not rated yet |
0
Vaccine adjuvant uses host DNA to boost pathogen recognition
Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective. No one knows, however, how they boost the immune response. In the March 19, 2013, issue of the Proceedings of ...
Medical research
Apr 05, 2013 |
5 / 5 (2) |
0
|
Major step toward an Alzheimer's vaccine
A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This ...
Alzheimer's disease & dementia
Jan 15, 2013 |
5 / 5 (4) |
0
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: ...
Medications
Aug 16, 2012 |
not rated yet |
0
Flu vaccine research: overcoming 'original sin'
(Medical Xpress) -- Scientists studying flu vaccines have identified ways to overcome an obstacle called "original antigenic sin," which can impair immune responses to new flu strains.
Immunology
Aug 13, 2012 |
3.7 / 5 (3) |
1
|
Keeping the flu away: Synthetic protein EP67 helps kick-start the immune system
San Diego State University researchers at the Donald P. Shiley BioScience Center may have found the secret to helping the immune system fight off the flu before it gets you sick.
Immunology
Jul 06, 2012 |
4 / 5 (4) |
0
|
Vaccine trial for Alzheimer's clears key hurdle
A vaccine which revives a promising but long-abandoned path to thwart Alzheimer's disease has cleared a key safety hurdle in human trials, researchers say.
Alzheimer's disease & dementia
Jun 07, 2012 |
5 / 5 (1) |
0
Research describes advantages of new vaccine adjuvant
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest ...
Medical research
Dec 12, 2011 |
5 / 5 (1) |
0
The H1N1 flu vaccine protects both pregnant women and newly-borns
The researchers studied the immune response of 107 pregnant women after they were injected with a single dose of non-adjuvant H1N1 vaccine. They concluded that the influenza shot boosted the immune response in pregnant women ...
Diseases, Conditions, Syndromes
Dec 07, 2011 |
not rated yet |
0
Award-winning research points toward Alzheimer's vaccine
An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research by a Georgia Health Sciences University graduate student.
Neuroscience
Sep 26, 2011 |
5 / 5 (2) |
0
Universal flu vaccine clinical trials show promise
A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu ...
Medications
Jun 07, 2011 |
5 / 5 (3) |
0
|
